Skip to content

A prospective study to evaluate long-term clinical outcomes of the GTS cementless femoral stem

A prospective study to evaluate long-term clinical outcomes of the GTS cementless femoral stem - H36 GTS international

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55672
Enrollment
23
Registered
2014-07-10
Start date
2014-10-06
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint wear Osteoarthritis

Interventions

None listed

Sponsors

Zimmer Biomet
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Male and non-pregnant females : >= 18 years and <= 70 years 2. Patients requiring primary THR, suitable for the use of the GTS stem. 3. The patient is diagnosed with osteoarthritis (OA) or avascular necrosis. 4. The individual is physically and mentally willing and able to comply with  postoperative functional evaluation and able to participate in an appropriate  rehabilitation schedule. 5. ASA classification score I-III. 6. Patients who signed the Ethics Committee approved specific Informed Consent  Form prior to surgery. 7. Surgical technique is planned to be Anterior Supine Intramuscular (ASI), or  patient has already received a GTS hip on the contralateral side.

Exclusion criteria

Exclusion criteria: 1. Patients who had a THA on contralateral side more than 6 months ago and the  rehabilitation period outcome is considered unsatisfactory or not good.  (Patients with contra-lateral THA >6 months ago with good outcome (Harris Hip  Score >85) can be included in the study). 2. Patients who had a THA on contralateral side less than 6 months ago. 3. Patients with a major surgical procedure during the 12 weeks before the  study-related operation.

Design outcomes

Primary

MeasureTime frame
Mean Harris Hip Score (HHS) at 2 years postoperative

Secondary

MeasureTime frame
-Radiographic evaluation: stability, incidence of radiolucencies around the prosthesis and bone remodeling - Patient satisfaction: EQ5D quality of life - Adverse Events/Complications (including revisions/removals). - Survivorship

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)